Range Low Price High Price Comment
30 days $0.470 $0.470 Thursday, 17th Aug 2023 CYAD stock ended at $0.470. During the day the stock fluctuated 0% from a day low at $0.470 to a day high of $0.470.
90 days $0.470 $0.470
52 weeks $0.460 $3.07

Historical Celyad SA prices

Date Open High Low Close Volume
2022-10-28 $1.05 $1.09 $1.05 $1.09 2 460
2022-10-27 $1.09 $1.09 $1.09 $1.09 2 407
2022-10-26 $1.04 $1.07 $0.99 $1.02 9 952
2022-10-25 $1.09 $1.09 $1.08 $1.08 15 444
2022-10-24 $1.09 $1.09 $1.05 $1.06 6 007
2022-10-21 $1.09 $1.11 $1.05 $1.08 2 438
2022-10-20 $1.10 $1.10 $1.09 $1.10 972
2022-10-19 $1.08 $1.11 $1.08 $1.11 1 022
2022-10-18 $1.12 $1.15 $1.11 $1.11 4 369
2022-10-17 $1.17 $1.17 $1.11 $1.11 1 589
2022-10-14 $1.13 $1.14 $1.10 $1.10 1 831
2022-10-13 $1.15 $1.15 $1.06 $1.10 16 103
2022-10-12 $1.15 $1.26 $1.15 $1.21 18 282
2022-10-11 $1.15 $1.18 $1.15 $1.17 4 641
2022-10-10 $1.20 $1.20 $1.15 $1.19 1 887
2022-10-07 $1.22 $1.28 $1.12 $1.17 5 097
2022-10-06 $1.28 $1.34 $1.27 $1.30 5 363
2022-10-05 $1.38 $1.38 $1.35 $1.35 1 058
2022-10-04 $1.45 $1.46 $1.34 $1.42 3 864
2022-10-03 $1.39 $1.40 $1.27 $1.27 3 312
2022-09-30 $1.34 $1.38 $1.24 $1.38 3 287
2022-09-29 $1.44 $1.45 $1.30 $1.39 7 555
2022-09-28 $1.50 $1.54 $1.45 $1.45 3 461
2022-09-27 $1.48 $1.48 $1.44 $1.44 1 085
2022-09-26 $1.49 $1.52 $1.44 $1.45 17 514
Click to get the best stock tips daily for free!

About Celyad SA

Celyad SA Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical... CYAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT